DNA Damage Repair (DDR) gene and VHL concurrent alterations in advanced clear cell Renal Cell Carcinoma (ccRCC) are association with good progression free survival with tyrosine kinase inhibitor therapy

Authors :: W. Zhai
J. Wang
N. He
J. Zhou
Y. Xue
Z. Yang
Y.. Chen
J. Hui
J. Haung
W. Kong
Y. Haung
W. Xue
Source :: European Urology. 79:S742
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Clear cell renal cell carcinoma
medicine.drug_class
business.industry
Urology
medicine
Cancer research
Progression-free survival
business
medicine.disease
DNA Damage Repair
Gene
Tyrosine-kinase inhibitor

Full Text Access

Tools